Maze Therapeutics revenue was $0.00 for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MAZE annual revenue was $167.5M, with Infinity% growth year-over-year.
MAZE past revenue growth
How has MAZE's revenue growth performed historically?
On Invalid Date, Maze Therapeutics (NASDAQ: MAZE) reported Q3 2025 revenue of $0.00 up 100% year over year. In the same quarter last year, Maze Therapeutics's revenue was $2.50 million.
What was Maze Therapeutics's revenue in 2024?
Maze Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $167.50 million, a Infinity% increase year over year.
How much does Maze Therapeutics make in a day?
Based on Maze Therapeutics annual revenue for the past two years, MAZE makes an average of $229,452.05 per day.
What was Maze Therapeutics's annual revenue growth in the past year?
As of Q1 2026, Maze Therapeutics's revenue has grown -100% year over year. This is 395.7 percentage points lower than the US Biotechnology industry revenue growth rate of 295.7%. Maze Therapeutics's revenue in the past year totaled $0.00.
How much does Maze Therapeutics make in a year?
Maze Therapeutics's revenue by year for the past two years is:
Maze Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $167.50 million, a Infinity% increase year over year.
Maze Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.